NLVP
New Leaf Venture Partners’s Crinetics Pharmaceuticals CRNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.06M | Hold |
141,000
| – | – | 7.66% | 4 |
|
2025
Q1 | $4.73M | Hold |
141,000
| – | – | 10.53% | 3 |
|
2024
Q4 | $7.21M | Hold |
141,000
| – | – | 9.64% | 3 |
|
2024
Q3 | $7.21M | Hold |
141,000
| – | – | 7.41% | 3 |
|
2024
Q2 | $6.32M | Hold |
141,000
| – | – | 7.68% | 3 |
|
2024
Q1 | $6.6M | Hold |
141,000
| – | – | 5.78% | 4 |
|
2023
Q4 | $5.02M | Hold |
141,000
| – | – | 4.04% | 6 |
|
2023
Q3 | $4.19M | Hold |
141,000
| – | – | 5.38% | 6 |
|
2023
Q2 | $2.54M | Hold |
141,000
| – | – | 2.18% | 7 |
|
2023
Q1 | $2.26M | Hold |
141,000
| – | – | 1.87% | 10 |
|
2022
Q4 | $2.58M | Hold |
141,000
| – | – | 1.87% | 10 |
|
2022
Q3 | $2.77M | Hold |
141,000
| – | – | 1.64% | 11 |
|
2022
Q2 | $2.63M | Hold |
141,000
| – | – | 1.7% | 12 |
|
2022
Q1 | $3.1M | Hold |
141,000
| – | – | 1.53% | 14 |
|
2021
Q4 | $4.01M | Hold |
141,000
| – | – | 1.45% | 15 |
|
2021
Q3 | $2.97M | Hold |
141,000
| – | – | 0.86% | 16 |
|
2021
Q2 | $44.3M | Hold |
141,000
| – | – | 11.37% | 2 |
|
2021
Q1 | $2.15M | Hold |
141,000
| – | – | 0.5% | 16 |
|
2020
Q4 | $1.99M | Hold |
141,000
| – | – | 0.46% | 14 |
|
2020
Q3 | $2.21M | Hold |
141,000
| – | – | 0.89% | 15 |
|
2020
Q2 | $2.47M | Hold |
141,000
| – | – | 0.71% | 15 |
|
2020
Q1 | $2.07M | Hold |
141,000
| – | – | 0.62% | 16 |
|
2019
Q4 | $3.54M | Hold |
141,000
| – | – | 0.77% | 14 |
|
2019
Q3 | $2.12M | Sell |
141,000
-26,700
| -16% | -$402K | 0.64% | 17 |
|
2019
Q2 | $4.19M | Hold |
167,700
| – | – | 1.12% | 14 |
|
2019
Q1 | $3.82M | Hold |
167,700
| – | – | 1.05% | 14 |
|
2018
Q4 | $5.03M | Hold |
167,700
| – | – | 1.38% | 13 |
|
2018
Q3 | $4.81M | Buy |
+167,700
| New | +$4.81M | 0.87% | 14 |
|